Generic Name	World Status	Originator	Primary Indication
amphotericin B, Gilead	Launched	Gilead Sciences	Infection, general
leishmaniasis vaccine, GSK	Phase I Clinical Trial	GlaxoSmithKline	Infection, leishmaniasis
miltefosine	Launched	AEterna Zentaris	Cancer, skin, general
sitamaquine	Phase II Clinical Trial	GlaxoSmithKline	Infection, leishmaniasis
aminosidine, iOWH	Registered	Institute for OneWorld Health	Infection, leishmaniasis
amphotericin B, BDSI	Preclinical	BioDelivery Sciences	Infection, leishmaniasis
leishmaniasis ther, Helix	Preclinical	Helix BioMedix	Infection, leishmaniasis
Table 1. Products in active development from preclinical to launched status